David Maxwell Hunter Chascsa

8PUBLICATIONS

30CO-AUTHORS

Medical biochemistry - lipidsHaematological tumoursMetabolic medicineCardiology (incl. cardiovascular diseases)Gene and molecular therapy

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (8)

Sort by Publication Date:

|Jun 26, 2026

Aspirin Use and Liver-Related Outcomes in Metabolic Dysfunction-Associated Steatotic Liver Disease: A Systematic Review and Meta-Analysis.

|May 06, 2025

Long-Term Outcomes of Fenofibrate for Treatment of Ischemic Cholangiopathy in Donation After Circulatory Death Liver Transplantation.

Channa R Jayasekera, Michele Barnhill, David M H Chascsa

|Jul 27, 2024

Exploring Varied Treatment Strategies for Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD).

Amani Elshaer, David M H Chascsa, Blanca C Lizaola-Mayo

|Jan 12, 2023

Long-term clinical outcomes of patients with COVID-19 and chronic liver disease: US multicenter COLD study.

Elizabeth S Aby, Ghady Moafa, Nyan Latt

|May 06, 2022

Special Considerations in the Management of HIV and Viral Hepatitis Coinfections in Liver Transplantation.

Josiah D McCain, David M Chascsa

|Jun 18, 2020

Update on Emerging Treatment Options for Primary Biliary Cholangitis.

Maria T Aguilar, David M Chascsa

Pageof 2

Frequent Collaborators

Hugo E Vargas

Bashar A Aqel

A P Keaveny

Elizabeth S Aby

Nyan Latt

Patricia P Bloom

Jose D Debes

Sunny Sandhu

Aalam Sohal

Sameeha Khalid

Frequent Collaborators

Hugo E Vargas

Bashar A Aqel

A P Keaveny

Elizabeth S Aby